Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 166 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Statements Of Operations [Abstract]      
Revenue         
Operating Expenses:      
Research and development, net of reimbursements 2,460,968 1,085,707 31,548,346
General and administrative 1,676,053 933,135 30,100,379
Depreciation and amortization 1,405    3,265,427
Loss on disposition of equipment   4,122 554,308
Total Operating Expenses 4,138,426 2,022,964 65,468,460
Loss From Operations (4,138,426) (2,022,964) (65,468,460)
Other Income and (Expense):      
Interest expense    (575) (1,967,215)
Gain on extinguishment of liability       260,000
Gain (loss) on change in fair value of derivative liabilities (12,561,071) 1,334,512 (16,041,077)
Total Other Income and (Expense) (12,561,071) 1,333,937 (17,748,292)
Net loss $ (16,699,497) $ (689,027) $ (83,216,752)
Net Loss Per Common Share - Basic and Diluted $ (0.66) $ (0.03)   
Weighted Average Number of Common Shares Outstanding - Basic and Diluted 25,228,299 21,391,665